The Tisch Cancer Institute

Latest from The Tisch Cancer Institute


Nursing Considerations for Using Selinexor in Multiple Myeloma

January 03, 2022

An expert from the Tisch Cancer Institute highlights the importance of medication adherence, nausea management, and proper hydration for patients being treated with selinexor for relapsed or refractory multiple myeloma.